Model
Edge
Mirati Therapeutics Inc.
MRTX
Filing Type
8-K
Filing Date
1/22/2024
Updated
1/23/24, 1:48 AM
Filing
8-K
Earnings Release
Exhibits
8-K
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2
EX-99.1
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events